Ticker LaunchCanada to US · Cross-listing · DRUG
Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc. (DRUG), a British Columbia-based company, cross-listed on Nasdaq on Nov 2, 2021, registering its securities on Form 8-A12B.
Bright Minds Biosciences is a biotechnology company incorporated in British Columbia in 2019. It is dedicated to developing therapeutics intended to improve the lives of patients with severe and life-altering diseases.
- Type
- Cross-listing
- US exchange
- Nasdaq
- Ticker
- DRUG
- Listed
- Nov 2, 2021
- Province
- British Columbia
- Registration form
- 8-A12B
- Security
- Common shares
- Sector
- Biotech & pharma
More on this listing for subscribers
- Analyst notes from the filings
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Filings
- Registration (8-A12B) Nov 2, 2021
- All filings on EDGAR CIK 1827401
Other Canadian companies listing in the US
- Telesat CorpNasdaq · Nov 18, 2021
- The Valens Company Inc.Nasdaq · Nov 17, 2021
- Defi Technologies Inc.Nasdaq · Nov 10, 2021
- Skeena Resources LtdNYSE · Oct 22, 2021
- The Very Good Food Company Inc.Nasdaq · Oct 7, 2021
- Tricon Residential Inc.NYSE · Oct 7, 2021